(EMAILWIRE.COM, December 22, 2018 ) According to the new market research report "Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 146.4 million in 2016 at a CAGR of 2.8%.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768

The base year for this study is 2016 and the forecast period is 2017–2022. 100–150 mm needles are the most commonly used amniocentesis needles and are expected to account for the largest share of the global market in 2017. The large share of this segment can be attributed to the fact that these needles are suitable for most patients on account of their optimal length.

Browse and in-depth TOC on "Amniocentesis Needle Market"
74 – Tables
34 - Figures
132 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html

This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.

Key Players:
The key players in the amniocentesis needles market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).

Browse Adjacent Bundle Market - https://www.marketsandmarkets.com/RequestBundleReport.asp?id=18541768